| Released | Contributor | Author | Title | Pages | Price |
| 7-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 |
| 7-Dec-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 |
| 7-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for LJPC | 13 |
$25 |
| 6-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for BIOTECHNOLOGY | 18 |
$49 |
| 6-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Comprehensive Rating Report | 48 |
$99 |
| 5-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| La Jolla Pharmaceutical | 5 |
$25 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | LA JOLLA PHARMACEUTICAL CO (LJPC=US) 2-weeks forecast | 1 |
$10 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: LA JOLLA PHARM -- LJPC | 1 |
$4 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: AVGN , CLDX , CRIS , FACT , LJPC , PPHM , VION -- DRUGS | 3 |
$4 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for La Jolla Pharmaceutical Company | 40 |
$65 |
0.01% Nasdaq 
0.22%
Research Reports
